Search
Dabrafenib mesylate is used in the treatment of metastatic melanoma. Dabrafenib mesylate is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.
| Items | Specification |
| Product name | Dabrafenib Mesylate |
| CAS | 1195768-06-9 |
| Appearance | White powder |
| Assay | ≥99% |
| Molecular Formula | C24H24F3N5O5S3 |
| Molecular Weight | 615.6680696 |
| EINECS | 689-167-4 |
| Product parameters | |
| Cas number: | 1195768-06-9 |
| Appearance: | White powder |
| Purity: | 99%min |
| Package details: | 25kg/drum |
| Brand: | Fortunachem |

Guaranteed purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية